Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Infectious Disease Diagnostics Testing Market Forecast: Value Set To Climb From $46.48 Billion To $65.49 Billion
The infectious disease diagnostics testing market size has experienced substantial expansion in recent years. It is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth has been driven by factors such as the increasing occurrence of infectious diseases, a surge in respiratory infection cases, the development of diagnostic laboratory facilities, heightened understanding of the importance of early disease detection, and increased governmental attention on managing diseases.
The infectious disease diagnostics testing market is expected to undergo significant expansion in the coming years. It is anticipated to grow to $65.49 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.0%. The projected growth during this period stems from factors such as the escalating risk of global pandemics, an increasing demand for rapid diagnostic solutions, growing investments in healthcare diagnostics, the expansion of disease surveillance programs, and a rising burden of tropical and viral diseases. Noteworthy trends during the forecast period encompass a surging demand for swift and early detection of infectious diseases, increasing adoption of point-of-care infectious disease tests, greater use of molecular diagnostics for pathogen identification, the broadening scope of diagnostic testing for both emerging and re-emerging infections, and an enhanced focus on large-scale disease screening and surveillance.
Get A Free Sample Report With In-Depth Market Insights:
Infectious Disease Diagnostics Testing Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of respiratory infections is projected to fuel the expansion of the infectious disease diagnostic testing market in the future. These infections target the respiratory system, encompassing the nose, throat, airways, and lungs. The growing number of respiratory infections stems from viral and bacterial spread via close contact with affected people, inadequate hygiene, congested living environments, and seasonal climatic shifts. Crucially, infectious disease diagnostic testing plays a vital role in diagnosing and managing respiratory infections by accurately pinpointing pathogens like bacteria and viruses within patient specimens. For example, data from February 2024 released by the Canadian Institute for Health Information, a Canada-based non-profit body, showed a 32% rise in hospitalizations for acute upper respiratory infections, climbing from 2,114 cases in 2022 to 2,797 cases in 2023. Consequently, the escalating occurrence of respiratory infections is a key driver for the infectious disease diagnostic testing market.
Infectious Disease Diagnostics Testing Market Segment Outlook: Which Categories Are Growing Fastest?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Infectious Disease Diagnostics Testing Market Industry Trends: What’s Reshaping Demand?
Leading companies in the infectious disease diagnostic testing market are advancing innovative technologies designed for the swift and reliable detection of critical infections. Infectious disease diagnostics focuses on identifying pathogens, such as bacteria, viruses, or parasites, to inform diagnosis and guide appropriate treatment. For instance, in January 2025, QIAGEN, a Germany-based biotechnology company, launched new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel. These were introduced alongside the previously authorized Respiratory SARS-CoV-2 Panel, all having secured approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system employs multiplex real-time PCR with single-use cartridges to simultaneously detect multiple pathogens, delivering results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels enhance diagnostic speed and accuracy compared to traditional methods, thereby enabling timely treatment, improving patient outcomes, and easing burdens on healthcare systems. The system additionally offers configurable setups and cloud connectivity for remote monitoring and efficient data management.
Infectious Disease Diagnostics Testing Market Industry Leaders And Competitive Landscape
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC
View The Full Infectious Disease Diagnostics Testing Market Report:
Infectious Disease Diagnostics Testing Market Regional Analysis And Leading Geography
North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model